- Home
- NVRO vs PBMWW Comparison
NVRO vs PBMWW Comparison
Compare NVRO & PBMWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVRO
- PBMWW
- Stock Information
- Founded
- NVRO 2006
- PBMWW N/A
- Country
- NVRO United States
- PBMWW Canada
- Employees
- NVRO N/A
- PBMWW 10
- Industry
- NVRO Medical/Dental Instruments
- PBMWW
- Sector
- NVRO Health Care
- PBMWW
- Exchange
- NVRO Nasdaq
- PBMWW Nasdaq
- Market Cap
- NVRO 134.5M
- PBMWW N/A
- IPO Year
- NVRO 2014
- PBMWW N/A
- Fundamental
- Price
- NVRO $3.71
- PBMWW $0.02
- Analyst Decision
- NVRO Hold
- PBMWW
- Analyst Count
- NVRO 14
- PBMWW 0
- Target Price
- NVRO $7.97
- PBMWW N/A
- AVG Volume (30 Days)
- NVRO 395.4K
- PBMWW N/A
- Earning Date
- NVRO 02-19-2025
- PBMWW N/A
- Dividend Yield
- NVRO N/A
- PBMWW N/A
- EPS Growth
- NVRO N/A
- PBMWW N/A
- EPS
- NVRO N/A
- PBMWW N/A
- Revenue
- NVRO $419,146,000.00
- PBMWW N/A
- Revenue This Year
- NVRO N/A
- PBMWW N/A
- Revenue Next Year
- NVRO $0.65
- PBMWW N/A
- P/E Ratio
- NVRO N/A
- PBMWW N/A
- Revenue Growth
- NVRO N/A
- PBMWW N/A
- 52 Week Low
- NVRO $3.52
- PBMWW N/A
- 52 Week High
- NVRO $21.66
- PBMWW N/A
- Technical
- Relative Strength Index (RSI)
- NVRO 38.60
- PBMWW N/A
- Support Level
- NVRO $3.60
- PBMWW N/A
- Resistance Level
- NVRO $3.90
- PBMWW N/A
- Average True Range (ATR)
- NVRO 0.29
- PBMWW 0.00
- MACD
- NVRO 0.00
- PBMWW 0.00
- Stochastic Oscillator
- NVRO 20.88
- PBMWW 0.00
About NVRO Nevro Corp.
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.
About PBMWW Psyence Biomedical Ltd. Warrant
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.